Aldeyra Therapeutics Inc (ALDX)
R&D Expense Growth
44.61%
Quarterly · Period ending:
ALDX R&D Expense Growth
Latest reported44.61%period ending
Latest reported44.61%period ending
ALDX Quarterly R&D Growth (QoQ) (0.00% → 44.61%)
Latest values, visible window
High-resolution chart · PNG
ALDX r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 44.6111% | |
| -44.0095% | |
| -20.7561% | |
| -36.148% | |
| 14.5744% | |
| -49.2597% | |
| 17.5905% | |
| -16.889% | |
| 142.0914% | |
| 43.86% | |
| -38.2579% | |
| -0.0178% | |
| -38.0296% | |
| 25.3796% | |
| -22.3417% | |
| -20.8023% | |
| 19.0966% | |
| -4.7275% | |
| -0.4106% | |
| 12.3744% | |
| 48.5107% | |
| 9.9328% | |
| 14.5863% | |
| 25.537% | |
| -26.3466% | |
| -31.0037% | |
| -40.7394% | |
| 52.1255% | |
| 35.8825% | |
| -8.1926% | |
| 8.4782% | |
| 16.0143% | |
| 2.9222% | |
| 19.0219% | |
| 56.6746% | |
| -8.0418% | |
| 14.2435% | |
| -2.2672% | |
| 1.9962% | |
| 19.2339% | |
| -19.2783% | |
| 12.8201% | |
| 49.8961% | |
| 66.2329% | |
| 9.9137% | |
| -19.0395% | |
| 17.398% | |
| 80.0954% | |
| 49.4353% | |
| 10.9702% | |
| -39.8898% | |
| 104.9039% | |
| 116.3639% | |
| 56.2209% | |
| 0% |